Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|February 18, 2016
Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding DeterminationKasia Kieltyka, Brian McAuliffe, Christopher Cianci, et al.Antimicrobial Agents and Chemotherapy|September 2, 2009
Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitorsLouis Alexander, Sharon Zhang, Brian McAuliffe, et al.Proteins|November 18, 2014
Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of actionDavid R Langley, S Roy Kimura, Prasanna Sivaprakasam, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2020
Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitorsManoj Patel, Christopher Cianci, Christopher W Allard, et al.The Journal of Antimicrobial Chemotherapy|October 17, 2013
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068Nannan Zhou, Beata Nowicka-Sans, Brian McAuliffe, et al.Antimicrobial Agents and Chemotherapy|November 15, 2021
GSK3640254 Is a Novel HIV-1 Maturation Inhibitor with an Optimized Virology ProfileIra Dicker, Jerry L Jeffrey, Tricia Protack, et al.Viruses|October 26, 2024
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937Brian McAuliffe, Paul Falk, Jie Chen, et al.Virology|April 20, 2010
Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodiesNannan Zhou, Li Fan, Hsu-Tso Ho, et al.Journal of Medicinal Chemistry|March 2, 2022
Design, Synthesis, and Preclinical Profiling of GSK3739936 (BMS-986180), an Allosteric Inhibitor of HIV-1 Integrase with Broad-Spectrum Activity toward 124/125 PolymorphsB Narasimhulu Naidu, Manoj Patel, Brian McAuliffe, et al.Antimicrobial Agents and Chemotherapy|September 3, 2025
Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499Chunfu Wang, Haichang Huang, Lourdes Valera, et al.Pageof 2